跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
DAPAGLIFLOZINA OLPHA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
DAPAGLIFLOZINA OLPHA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Olpha As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 10, 2026
Approval ID
9baf5349989edef7
Company
Olpha As
Type
Standard
Approval Details
Approval Id
9baf5349989edef7
Drug Cima Aemps Name
DAPAGLIFLOZINA OLPHA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
91595
Holder Company Name
Olpha As
Marketing Company Name
Olpha As
Authorization Date
2026-09-10
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Olpha As
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 10, 2026
Approval ID
9baf5349989edef7
Type
Standard
Back to CIMA-AEMPS Approvals
DAPAGLIFLOZINA OLPHA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details